Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Most retail investors discover IPOs through excitement: the first-day pop, the breathless media coverage, the sense that something historic is being priced. What they rarely pay attention to is a date buried inside the IPO prospectus, usually 90 to 180 days after listing, when the rules of the game change completely. That is the lockup expiry date, and for the patient contrarian, it is one of the most reliable recurring setups in public markets.
Most retail investors discover IPOs through excitement: the first-day pop, the breathless media coverage, the sense that something historic is being priced. What they rarely pay attention to is a date buried inside the IPO prospectus, usually 90 to 180 days after listing, when the rules of the game change completely. That is the lockup expiry date, and for the patient contrarian, it is one of the most reliable recurring setups in public markets.
When a company lists publicly, its founders, employees, venture capital backers, and early institutional investors are prohibited from selling their shares for a defined period. This restriction, known as the lockup period, is not mandated by the SEC but is a contractual agreement with the IPO underwriters. As Charles Schwab explains, lockups exist to prevent a flood of insider shares from immediately hitting the market after listing, which would suppress the price and signal a lack of confidence in the company’s prospects.
The standard lockup period runs 180 days, or roughly six months. During that window, the publicly traded float is artificially constrained. Once the lockup expires, the supply of available shares can increase dramatically, sometimes by multiples of the original float, as insiders and venture capital funds who have been waiting six months to monetise their positions finally have permission to sell.
The market understands this dynamic well. Research by Ofek and Richardson found that stock prices typically decline 1% to 3% around lockup expiry while trading volume increases by approximately 40%. Foundational academic work by Field and Hanka (2001), studying 450 IPOs listed on NYSE and NASDAQ, confirmed that lockup expirations are accompanied by statistically significant negative abnormal returns, with venture capital-backed firms experiencing the sharpest declines due to the structural pressure on VC funds to return capital to their own investors. In practice, the price decline often begins several days before expiry as sophisticated investors anticipate the incoming supply.
Here is where most casual observers misread the signal. They see the approaching lockup expiry and sell to get ahead of the drop. In doing so, they often create the drop themselves, before the actual selling even begins. By the time the lockup expires, a meaningful portion of the price decline may already be priced in. The contrarian does not panic-sell before lockup expiry. They watch the selling pressure unfold, wait for it to exhaust itself, and then buy into the stabilised price once the supply overhang clears.
The logic is identical to the short interest play: when a predictable, mechanical event creates artificial downward price pressure that has nothing to do with the underlying business’s fundamentals, you have a potential mispricing. The setup is repeatable precisely because it is calendar-driven. The expiry date is disclosed in the prospectus. Anyone can see it coming. And yet the selling pressure still materialises with remarkable consistency, suggesting the market never fully adjusts.
Research cited by IPOHub notes that Uber experienced a 17% drop in its stock price in the days approaching its lockup expiration in 2019, largely attributed to the anticipated supply increase rather than any fundamental deterioration in the business. That 17% represented an entry point, not a death knell.
No recent example illustrates the layered complexity of modern IPO lockups better than Figma (NYSE: FIG). The company listed on July 30, 2025, at an IPO price of $33 per share. By the second trading day, the stock had surged to an intraday high of approximately $143, a move of over 300% that reflected intense institutional demand for a profitable design software company with strong growth metrics.
What followed was a systematic unravelling driven almost entirely by lockup mechanics, not fundamental deterioration. According to Benzinga, Figma’s stock had fallen approximately 80% from its all-time high to around $22.51 by early February 2026, sitting well below its $33 IPO price. For thousands of employees who had waited a decade for the company to go public, the 180-day lockup functioned as a legal barrier between them and life-changing wealth.
The lockup structure itself was unusually complex. SEC filings and coverage by InvestorPlace document three distinct release windows: a performance-based early release of 25% of locked shares on September 5, 2025 (36 days after IPO), an additional release tied to Q3 earnings on November 14, 2025, and the standard 180-day expiration on January 27, 2026. A final and massive VC lockup covering approximately 54% of Class A shares is set to expire on August 31, 2026, representing roughly $7 billion in shares at current prices.
For the contrarian investor paying attention to these dates, each window was both a warning and a potential opportunity. The September 5 expiry triggered a swift descent from $80. The November window coincided with executive selling documented in SEC Form 4 filings, with insiders transacting at $43 to $48 per share. By January 27, the stock was trading near $22, well below the IPO price. The August 2026 VC lockup expiry now looms as the next inflection point worth monitoring.
Figma’s revenue grew 38% year over year in its most recent quarterly filing. The business is not broken. The selling pressure was structural and calendar-driven. Whether the stock stabilises after August 2026 when the final supply overhang clears is precisely the kind of thesis the lockup contrarian builds.
The mechanical playbook is straightforward, though execution requires patience and discipline.
First, read the prospectus. Every IPO files an S-1 document with the SEC’s EDGAR database, which discloses the full lockup agreement including duration, which shareholders are subject to it, and whether any performance-based early release conditions exist. Understanding the lockup architecture before the IPO lists gives you a significant informational advantage over retail buyers who focus only on the opening-day price.
Second, note the percentage of shares subject to lockup relative to the total float. The more shares locked up, the greater the supply shock at expiry. A company where insiders hold 70% of total shares and the public float is only 15% is a fundamentally different risk profile than one where early investors hold a modest stake.
Third, monitor the days leading up to expiry rather than the expiry date itself. Cooley’s CapitalXchange analysis highlights that many sophisticated investors begin repositioning in the final weeks before lockup expiry, meaning the price movement often leads the actual event by ten to twenty days.
Fourth, and most critically, do not buy into the falling price. Wait for the selling to exhaust itself. The contrarian edge comes from buying after the supply overhang has cleared, not during it. The difference between an entry on the day of expiry and an entry two weeks later can be significant.
The strategy carries a real and important caveat. Lockup expiry pressure is temporary and mechanical, but it can expose underlying fundamental weakness that was previously obscured by the restricted float. Companies where the business model itself is deteriorating, where competition is accelerating, or where the original IPO valuation was simply absurd will not recover after the lockup supply clears. The selling pressure is the trigger, not the cause.
The contrarian framework requires a two-step filter: first, confirm that the price decline is primarily driven by lockup mechanics rather than deteriorating fundamentals; second, confirm that the business at the post-lockup price represents genuine value. A company that was priced at 30 times revenue at IPO and falls to 15 times revenue after lockup expiry is not automatically cheap, it may simply be less expensive than it was before.
Venture capital-backed technology companies carry the highest structural risk, precisely because VC fund economics require capital return. Academic research cited by SciELO Brazil found that private equity-backed companies experience lockup expiry declines approximately 5% to 6% larger than their non-PE counterparts, reflecting the urgency with which institutional sellers approach the unlock date.
The IPO lockup expiry play works because it combines two things the market consistently misprices: calendar predictability and supply mechanics. Most retail investors either ignore the expiry entirely or panic-sell ahead of it. Both responses hand the patient contrarian an opportunity.
The Figma story in 2025 and 2026 is a vivid reminder that lockup structures have grown more complex, with staggered releases, performance-based triggers, and extended VC agreements that create multiple inflection points rather than a single clean event. Understanding the full lockup architecture of any recent IPO is now as important as understanding its income statement.
The final lesson is one of temperament. This strategy demands comfort with holding a thesis that looks wrong for weeks while the selling pressure plays out. That discomfort is, as it usually is in contrarian investing, the primary source of the edge.
This article is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.